Cancer
Conditions
Interventions
the Gustave Roussy Immune Score GRIm score
Sponsors
Sarah Hamdy
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients diagnosed Head and neck cancers Newly diagnosed HNC either early ,locally advanced.
Exclusion criteria
Exclusion criteria: • pateints with metastatic HNCS • Patients with a history of other malignancies within the last 5 years (except for adequately treated basal cell or squamous cell skin cancer, or carcinoma in situ of the cervix). • Patients receiving palliative care only. • Patients with known inflammatory bowel disease or other severe autoimmune conditions that might confound immune markers. • Patients currently on immunosuppressants or high-dose corticosteroids (unless tapering off )..
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the predictive and prognostic value of the Gustave Roussy Immune Score GRIm-score | — |
Secondary
| Measure | Time frame |
|---|---|
| disease free survival (DFS)which is defined as time from curative treatment (surgery) until the disease recurs or death | — |
Countries
Egypt
Contacts
Public ContactSarah Hamdy
residant doctor at Clinical Oncology and Nuclear Medicine Assiut university
Outcome results
None listed